Bartlett K, Ghneim H K, Stirk H J, Wastell H
J Inherit Metab Dis. 1985;8 Suppl 1:46-52. doi: 10.1007/BF01800659.
There appear to be at least two underlying aetiologies for combined carboxylase deficiency; firstly, a failure of biotinylation of apocarboxylases due to a mutation of holocarboxylase synthetase (EC 6.3.4.10) which results in an enzyme with a high Km with respect to biotin and secondly, a failure of biotinylation due to a lowered availability of biotin due to biotinidase deficiency (EC 3.5.1.12). In both these disorders secondary defects of all four biotin-dependent carboxylases result which in turn causes the excretion of the metabolites characteristic of the isolated carboxylase deficiencies. In addition, both disorders respond biochemically and clinically to the administration of large amounts of biotin.
联合羧化酶缺乏症似乎至少有两种潜在病因;首先,由于全羧化酶合成酶(EC 6.3.4.10)突变导致脱辅基羧化酶生物素化失败,这会产生一种对生物素具有高Km值的酶;其次,由于生物素酶缺乏(EC 3.5.1.12)导致生物素可用性降低,从而导致生物素化失败。在这两种疾病中,所有四种生物素依赖性羧化酶都会出现继发性缺陷,进而导致孤立羧化酶缺乏症特征性代谢产物的排泄。此外,这两种疾病在生化和临床上对大量生物素的给药均有反应。